Literature DB >> 8487948

Cholecystokinin-dependent regulation of host dopamine inputs to striatal grafts.

D J Sirinathsinghji1, R P Heavens, E M Torres, S B Dunnett.   

Abstract

Intrastriatal infusions of cholecystokinin-8-sulphate in the rat exerts a dose-dependent inhibition of dopamine-release from nigrostriatal terminals in the neostriatum, as measured by push-pull perfusion. This effect is abolished by excitotoxic lesions of the neostriatum, which, along with behavioural, electrophysiological and receptor binding studies, suggests that cholecystokinin exerts its action indirectly on dopamine release via receptors located on intrinsic striatal neurons. Grafts of embryonic striatum implanted in the lesioned striatum become innervated by host-derived dopamine axons and restore the response of those host neurons to cholecystokinin infusion. This suggests that the innervation of the grafts by dopaminergic axons of the host brain does not simply provide a tonic input to the grafts, but rather represents a phasic input that is under dynamic local regulation by graft-host feedback influences from the transplanted neurons themselves.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8487948     DOI: 10.1016/0306-4522(93)90613-k

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

Review 1.  Cell therapy in Huntington's disease.

Authors:  Stephen B Dunnett; Anne E Rosser
Journal:  NeuroRx       Date:  2004-10

2.  Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology.

Authors:  T B Freeman; F Cicchetti; R A Hauser; T W Deacon; X J Li; S M Hersch; G M Nauert; P R Sanberg; J H Kordower; S Saporta; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Embryonic striatal grafts reverse the disinhibitory effects of ibotenic acid lesions of the ventral striatum.

Authors:  P J Reading; S B Dunnett
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

4.  Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration.

Authors:  F Cicchetti; S Saporta; R A Hauser; M Parent; M Saint-Pierre; P R Sanberg; X J Li; J R Parker; Y Chu; E J Mufson; J H Kordower; T B Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

Review 5.  Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient.

Authors:  Amy E Reddington; Anne E Rosser; Stephen B Dunnett
Journal:  Front Cell Neurosci       Date:  2014-12-02       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.